- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/11 - Orthomyxoviridae, e.g. influenza virus
Patent holdings for IPC class C07K 14/11
Total number of patents in this class: 623
10-year publication summary
|
16
|
18
|
31
|
35
|
26
|
27
|
25
|
33
|
34
|
20
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Medicago Inc. | 135 |
20 |
| Janssen Vaccines & Prevention B.V. | 311 |
17 |
| Sanofi Pasteur Inc. | 378 |
17 |
| Aramis Biotechnologies Inc. | 57 |
17 |
| Icahn School of Medicine at Mount Sinai | 979 |
15 |
| FluGen, Inc. | 36 |
14 |
| Intervet International B.V. | 1300 |
12 |
| Longhorn Vaccines and Diagnostics, LLC | 90 |
10 |
| Intervet Inc. | 903 |
9 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2919 |
9 |
| Peptcell Limited | 27 |
8 |
| Duke University | 3135 |
6 |
| Academia Sinica | 952 |
6 |
| AVIR Green Hills Biotechnology Research Development Trade AG | 10 |
6 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3220 |
6 |
| Seqirus Inc. | 227 |
5 |
| The Regents of the University of California | 20315 |
4 |
| Massachusetts Institute of Technology | 10161 |
4 |
| Bionor Immuno AS | 20 |
4 |
| Folia Biotech Inc. | 10 |
4 |
| Other owners | 430 |